119 related articles for article (PubMed ID: 11454669)
1. Frequent loss of estrogen receptor-beta expression in prostate cancer.
Horvath LG; Henshall SM; Lee CS; Head DR; Quinn DI; Makela S; Delprado W; Golovsky D; Brenner PC; O'Neill G; Kooner R; Stricker PD; Grygiel JJ; Gustafsson JA; Sutherland RL
Cancer Res; 2001 Jul; 61(14):5331-5. PubMed ID: 11454669
[TBL] [Abstract][Full Text] [Related]
2.
Zhou C; Yu C; Guo L; Wang X; Li H; Cao Q; Li F
Biomed Res Int; 2018; 2018():1439712. PubMed ID: 30018975
[TBL] [Abstract][Full Text] [Related]
3. ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis.
Chang X; Wang H; Yang Z; Wang Y; Li J; Han Z
Medicine (Baltimore); 2023 Jun; 102(23):e33937. PubMed ID: 37335680
[TBL] [Abstract][Full Text] [Related]
4. Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor.
Souza DS; Macheroni C; Pereira GJS; Vicente CM; Porto CS
Front Endocrinol (Lausanne); 2023; 14():1124111. PubMed ID: 36936148
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of estrogen receptors in patients who underwent prostatectomy for non‑metastatic prostate cancer.
Aydın YM; Şahin AB; Dölek R; Vuruşkan BA; Ocakoğlu G; Vuruşkan H; Yavaşcaoğlu İ; Coşkun B
Oncol Lett; 2023 Feb; 25(2):78. PubMed ID: 36742361
[TBL] [Abstract][Full Text] [Related]
6. Embryologic and hormonal contributors to prostate cancer in transgender women.
Gaglani S; Purohit RS; Tewari AK; Kyprianou N; Lundon DJ
Am J Clin Exp Urol; 2022; 10(2):63-72. PubMed ID: 35528466
[TBL] [Abstract][Full Text] [Related]
7. Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions.
Farkas S; Szabó A; Hegyi AE; Török B; Fazekas CL; Ernszt D; Kovács T; Zelena D
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453610
[TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment.
Tong D
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383112
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone, Cancer, and Aging.
Schwartz AG
Aging Dis; 2022 Apr; 13(2):423-432. PubMed ID: 35371612
[TBL] [Abstract][Full Text] [Related]
10. Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers.
Chimento A; De Luca A; Avena P; De Amicis F; Casaburi I; Sirianni R; Pezzi V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163166
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma.
Pratap UP; Sareddy GR; Liu Z; Venkata PP; Liu J; Tang W; Altwegg KA; Ebrahimi B; Li X; Tekmal RR; Viswanadhapalli S; McHardy S; Brenner AJ; Vadlamudi RK
Neurooncol Adv; 2021; 3(1):vdab099. PubMed ID: 34485908
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.
Božović A; Mandušić V; Todorović L; Krajnović M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562134
[TBL] [Abstract][Full Text] [Related]
13. Association between estrogen receptor β polymorphisms and prostate cancer in a Slovak population.
Jurečeková J; Sivoňová MK; Drobková H; Híveš M; Evin D; Kliment J; Dobrota D
Oncol Lett; 2021 Mar; 21(3):214. PubMed ID: 33510815
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation.
Lafront C; Germain L; Weidmann C; Audet-Walsh É
Sci Rep; 2020 Mar; 10(1):4024. PubMed ID: 32132580
[TBL] [Abstract][Full Text] [Related]
15. Ventral prostate and mammary gland phenotype in mice with complete deletion of the ERβ gene.
Warner M; Wu WF; Montanholi L; Nalvarte I; Antonson P; Gustafsson JA
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4902-4909. PubMed ID: 32075916
[TBL] [Abstract][Full Text] [Related]
16. New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases.
Lu J; Shang X; Zhong W; Xu Y; Shi R; Wang X
Acta Pharm Sin B; 2020 Jan; 10(1):91-104. PubMed ID: 31998606
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor β inhibits prostate cancer cell proliferation through downregulating TGF-β1/IGF-1 signaling.
Xiao L; Xiao M; Zou M; Xu W
Int J Clin Exp Pathol; 2017; 10(8):8569-8576. PubMed ID: 31966711
[TBL] [Abstract][Full Text] [Related]
18. Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice.
Liu M; Du Y; Li H; Wang L; Ponikwicka-Tyszko D; Lebiedzinska W; Pilaszewicz-Puza A; Liu H; Zhou L; Fan H; Wang M; You H; Wolczynnski S; Rahman N; Guo YD; Li X
Front Oncol; 2019; 9():1110. PubMed ID: 31696058
[TBL] [Abstract][Full Text] [Related]
19. Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer.
Di Zazzo E; Galasso G; Giovannelli P; Di Donato M; Bilancio A; Perillo B; Sinisi AA; Migliaccio A; Castoria G
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31548498
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer.
Shen Y; Cao J; Liang Z; Lin Q; Wang J; Yang X; Zhang R; Zong J; Du X; Peng Y; Zhang J; Shi J
Cell Commun Signal; 2019 May; 17(1):50. PubMed ID: 31122254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
